Appointments

866.320.4573

Submit a Form

Questions

800.223.2273

Submit a Form

Live Chat hours:  M-F 9 a.m. - 3 p.m. ET

Expand Content

Diseases & Conditions

Olivopontocerebellar Atrophy

What is Olivopontocerebellar Atrophy?

Olivopontocerebellar atrophy (OPCA) is a term that describes the degeneration of neurons in specific areas of the brain – the cerebellum, pons, and inferior olives. OPCA is present in several neurodegenerative syndromes, including inherited and non-inherited forms of ataxia (such as the hereditary spinocerebellar ataxia known as Machado-Joseph disease) and multiple system atrophy (MSA), with which it is primarily associated. www.ninds.nih.gov

OPCA may also be found in the brains of individuals with prion disorders and inherited metabolic diseases. The characteristic areas of brain damage that indicate OPCA can be seen by imaging the brain using CT scans or MRI studies.

Is there any treatment?

There is no specific treatment for OPCA. Physicians may try different medications to treat the ataxia, tremor, and rigidity that are associated with the disorder. Other treatments are directed at specific symptoms. Stiffness, spasms, sleep disorders, depression, and tremor may be improved with medication. A physical therapist may be helpful in establishing a routine of exercise and stretching, and in obtaining devices or appliances to assist in walking and other daily activities.

What is the prognosis?

There is no cure for OPCA. The disorder is slowly progressive with death usually occurring approximately 20 years after onset.

What research is being done?

The NINDS supports and conducts a broad range of basic and clinical research on cerebellar degeneration, including work aimed at finding the cause(s) of OPCA and ways to treat, cure, and, ultimately, prevent the disease. There has been great progress recently since the genes for several of the hereditary forms of OPCA have been found.

Organizations

National Ataxia Foundation (NAF)

2600 Fernbrook Lane North, Suite 119
Minneapolis, MN 55447-4752
Phone: 763.553.0020
Fax: 763.553.0167
Email: naf@ataxia.org
Website: www.ataxia.org

National Organization for Rare Disorders (NORD)

55 Kenosia Avenue
Danbury, CT 06810
Phone: 203.744.0100 Voice Mail: 800.999.NORD (6673)
Fax: 203.798.2291
Email: orphan@rarediseases.org
Website: www.rarediseases.org

Source: National Institutes of Health; National Institute of Neurological Disorders and Stroke

Can't find the health information you’re looking for?

This information is provided by the Cleveland Clinic and is not intended to replace the medical advice of your doctor or health care provider. Please consult your health care provider for advice about a specific medical condition. This document was last reviewed on: 3/8/2012...#6072